X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1367) 1367
anti-vegf (1194) 1194
humans (1094) 1094
ophthalmology (1055) 1055
bevacizumab (836) 836
ranibizumab (702) 702
vascular endothelial growth factor (609) 609
female (554) 554
vascular endothelial growth factor a - antagonists & inhibitors (521) 521
male (519) 519
endothelial growth-factor (494) 494
macular degeneration (491) 491
anti-vegf therapy (472) 472
angiogenesis inhibitors - therapeutic use (407) 407
intravitreal injections (400) 400
aged (396) 396
angiogenesis (351) 351
animals (345) 345
age-related macular degeneration (333) 333
middle aged (332) 332
eye diseases (279) 279
oncology (268) 268
angiogenesis inhibitors - administration & dosage (262) 262
choroidal neovascularization (257) 257
genetic structures (246) 246
care and treatment (238) 238
cancer (236) 236
diabetic retinopathy (232) 232
treatment outcome (231) 231
tomography, optical coherence (229) 229
retrospective studies (228) 228
aflibercept (227) 227
aged, 80 and over (227) 227
vegf (210) 210
fluorescein angiography (209) 209
optical coherence tomography (209) 209
retina (204) 204
therapy (203) 203
follow-up studies (202) 202
visual acuity (200) 200
neovascularization (196) 196
diabetic macular edema (193) 193
photodynamic therapy (193) 193
sense organs (186) 186
medicine & public health (180) 180
injection (173) 173
analysis (163) 163
adult (158) 158
intravitreal injection (153) 153
visual acuity - physiology (153) 153
pharmacology & pharmacy (151) 151
antibodies, monoclonal, humanized (150) 150
anti-vegf treatment (149) 149
edema (148) 148
endothelial growth factors (138) 138
choroidal neovascularization - drug therapy (136) 136
diabetes (136) 136
mice (136) 136
wet macular degeneration - drug therapy (134) 134
research (131) 131
physiological aspects (130) 130
antibodies, monoclonal, humanized - therapeutic use (127) 127
retinopathy (126) 126
patients (125) 125
macular degeneration - drug therapy (124) 124
macular edema (118) 118
degeneration (117) 117
age (114) 114
angiogenesis inhibitors - adverse effects (114) 114
macular edema - drug therapy (114) 114
prospective studies (112) 112
article (110) 110
expression (110) 110
chemotherapy (109) 109
health aspects (109) 109
avastin (108) 108
vascular endothelial growth factor a - metabolism (108) 108
intravitreal bevacizumab (106) 106
drug therapy (103) 103
review (101) 101
medical research (100) 100
tumors (100) 100
anti-vegf antibody (99) 99
angiogenesis inhibitors - pharmacology (95) 95
medicine, research & experimental (94) 94
verteporfin (94) 94
amd (93) 93
angiogenesis inhibitors (91) 91
antibodies, monoclonal - therapeutic use (91) 91
eye (91) 91
safety (91) 91
diabetic retinopathy - drug therapy (90) 90
in-vivo (88) 88
neovascularization, pathologic - drug therapy (88) 88
retinal vein occlusion (86) 86
antibodies, monoclonal, humanized - administration & dosage (85) 85
time factors (85) 85
efficacy (84) 84
risk factors (84) 84
metastasis (82) 82
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2010) 2010
German (120) 120
French (118) 118
Spanish (25) 25
Korean (17) 17
Russian (14) 14
Turkish (9) 9
Czech (7) 7
Japanese (7) 7
Chinese (4) 4
Slovenian (3) 3
Polish (2) 2
Slovak (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biomolecules, ISSN 2218-273X, 06/2019, Volume 9, Issue 6, p. 243
The anti-fibrotic properties of ranibizumab have been well documented. As an antagonist to vascular endothelial growth factor (VEGF), ranibizumab works by... 
anti-VEGF | ranibizumab | trabeculectomy
Journal Article
Journal Article
Ocular Immunology and Inflammation, ISSN 0927-3948, 2019, pp. 1 - 7
Journal Article
Retina, ISSN 0275-004X, 05/2016, Volume 36, Issue 5, pp. 909 - 913
Journal Article
Journal Francais d'Ophtalmologie, ISSN 0181-5512, 12/2018, Volume 41, Issue 10, pp. 963 - 967
Introduction: Intravitreal injections of medication are designed to obtain a high concentration in the posterior segment. We conducted a retrospective study of... 
Vitreous | Intravitreal injection | Anti-VEGF | Macular edema
Journal Article
Journal Francais d'Ophtalmologie, ISSN 0181-5512, 11/2018, Volume 41, Issue 9, pp. 862 - 867
Purpose: To update the recommendations of the France Macula Federation for treatment of wet age-related macular degeneration (AMD). Methods: Analysis of... 
Ranibizumab | Wet AMD | Anti-VEGF | Aflibercept | Bevacizumab
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 05/2018, Volume 235, Issue 5, pp. 616 - 621
Journal Article
Archivos de la Sociedad Espanola de Oftalmologia, ISSN 0365-6691, 01/2019, Volume 94, Issue 1, pp. 41 - 44
A 55 year-old female patient with unilateral Acute Retinal Necrosis (ARN) developed macular oedema (MO) after the resolution of her necrosis. The macular... 
Acute retinal necrosis | Macular oedema | Anti-VEGF
Journal Article
Ophthalmologica, ISSN 0030-3755, 2019, pp. 1 - 15
The current body of evidence on the efficacy and safety of anti-VEGFs for macular oedema secondary to branch retinal vein occlusion (BRVO) is steadily growing... 
Retinal vein occlusion | Anti-VEGF | VEGF | Macular oedema | Meta-analysis
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 05/2006, Volume 26, Issue 5, pp. 495 - 511
Purpose: To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin, Genentech Inc.) for the treatment of neovascular age-related macular... 
ANTI-VEGF ANTIBODY | THERAPY | PHARMACOKINETICS | MEMBRANES | OPHTHALMOLOGY | MONOCLONAL-ANTIBODY | CHOROIDAL NEOVASCULARIZATION | RANIBIZUMAB | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | FAMILY
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 09/2019, Volume 103, Issue 9, p. 1337
AimsTo compare 24 months outcomes of eyes with retinal angiomatous proliferations (RAPs) treated with antivascular endothelial growth factor (anti-VEGF) with a... 
anti-VEGF | type 3 CNV | choroidal neovascularisation | visual outcomes | age-related macular degeneration | retinal angiomatous proliferation
Journal Article
Ophthalmology, ISSN 0161-6420, 02/2018, Volume 125, Issue 2, pp. 237 - 244
To investigate when retinal pigment epithelium (RPE) tears occur and their associated treatment patterns and long-term visual outcomes in patients with... 
ANTI-VEGF THERAPIES | AMD | OPHTHALMOLOGY | OPTICAL COHERENCE TOMOGRAPHY | BEVACIZUMAB | RANIBIZUMAB | Index Medicus
Journal Article
Expert Review of Ophthalmology, ISSN 1746-9899, 03/2018, Volume 13, Issue 2, pp. 87 - 103
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 10/2015, Volume 133, Issue 10, pp. 1159 - 1164
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.